These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 34702726)

  • 1.
    Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
    Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.
    Jiang YK; Shuai YJ; Ding HM; Zhang H; Huang C; Wang L; Sun JY; Wei WJ; Xiao XY; Jiang GS
    Curr Med Sci; 2023 Jun; 43(3):560-571. PubMed ID: 37142816
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Deng J; Zhang J; Ye Y; Liu K; Zeng L; Huang J; Pan L; Li M; Bai R; Zhuang L; Huang X; Wu G; Wei L; Zheng Y; Su J; Zhang S; Chen R; Lin D; Zheng J
    Cancer Res; 2021 Oct; 81(20):5268-5283. PubMed ID: 34362795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WTAP Targets the METTL3 m
    Sacco MT; Bland KM; Horner SM
    J Virol; 2022 Nov; 96(22):e0099722. PubMed ID: 36314819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
    Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer.
    Huang C; Yang Y; Wang X; Chen S; Liu Z; Li Z; Tang X; Zhang Q
    Int J Biol Sci; 2024; 20(9):3570-3589. PubMed ID: 38993556
    [No Abstract]   [Full Text] [Related]  

  • 12. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
    Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
    FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
    Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
    Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer.
    Zhang H; Xiao X; Wei W; Huang C; Wang M; Wang L; He Y; Sun J; Jiang Y; Jiang G; Zhang X
    Mol Cancer; 2021 Apr; 20(1):70. PubMed ID: 33874956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
    Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
    Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
    Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
    Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.